These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15542509)

  • 1. Cyclooxygenase 1 is required for pH control at the mouse gastric surface.
    Baumgartner HK; Starodub OT; Joehl JS; Tackett L; Montrose MH
    Gut; 2004 Dec; 53(12):1751-7. PubMed ID: 15542509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous cyclo-oxygenase activity regulates mouse gastric surface pH.
    Baumgartner HK; Kirbiyik U; Coskun T; Chu S; Montrose MH
    J Physiol; 2002 Nov; 544(3):871-82. PubMed ID: 12411530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
    Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
    Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.
    Takeuchi K; Tanaka A; Hayashi Y; Kubo Y
    Dig Dis Sci; 2004 Feb; 49(2):180-7. PubMed ID: 15104355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclooxygenase-2 in gastric mucosal defense.
    Peskar BM; Maricic N; Gretzera B; Schuligoi R; Schmassmann A
    Life Sci; 2001 Nov; 69(25-26):2993-3003. PubMed ID: 11758826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase isozymes involved in adaptive functional responses in rat stomach after barrier disruption.
    Takeeda M; Yamato M; Kato S; Takeuchi K
    J Pharmacol Exp Ther; 2003 Nov; 307(2):713-9. PubMed ID: 12975491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.
    Tanaka A; Araki H; Hase S; Komoike Y; Takeuchi K
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():90-101. PubMed ID: 11966529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric acid secretion in cyclooxygenase-1 deficient mice.
    Borrelli F; Welsh NJ; Sigthorsson G; Simpson R; Palizban A; Bjarnason I; Tavares IA
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1365-70. PubMed ID: 11012484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritant-induced cyclooxygenase-2 is involved in the defense mechanism of the gastric mucosa in mice.
    Miyake K; Tsukui T; Wada K; Tatsuguchi A; Futagami S; Hiratsuka T; Shinoki K; Iizumi T; Akamatsu T; Sakamoto C; Kobayashi M
    J Gastroenterol; 2002; 37(3):164-71. PubMed ID: 11931528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs.
    Tanaka A; Araki H; Komoike Y; Hase S; Takeuchi K
    J Physiol Paris; 2001; 95(1-6):21-7. PubMed ID: 11595414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice.
    Mizuno H; Sakamoto C; Matsuda K; Wada K; Uchida T; Noguchi H; Akamatsu T; Kasuga M
    Gastroenterology; 1997 Feb; 112(2):387-97. PubMed ID: 9024292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning.
    Camitta MG; Gabel SA; Chulada P; Bradbury JA; Langenbach R; Zeldin DC; Murphy E
    Circulation; 2001 Nov; 104(20):2453-8. PubMed ID: 11705824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2.
    Brzozowski T; Konturek PC; Konturek SJ; Schuppan D; Drozdowicz D; KwiecieĊ„ S; Majka J; Nakamura T; Hahn E
    Digestion; 2001; 64(1):15-29. PubMed ID: 11549833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo action of trefoil factor 2 (TFF2) to speed gastric repair is independent of cyclooxygenase.
    Xue L; Aihara E; Podolsky DK; Wang TC; Montrose MH
    Gut; 2010 Sep; 59(9):1184-91. PubMed ID: 20587547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
    Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
    Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.